$ANAC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anacor Pharmaceuticals, Inc.. Get notifications about new insider transactions in Anacor Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 14.22 | 15,000 | 213,300 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.11 | 15,000 | 76,650 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.20 | 12,500 | 65,000 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 6.74 | 15,000 | 101,100 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 6.92 | 30,000 | 207,600 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | D | 99.25 | 33,886 | 3,363,186 | 0 | 33.9 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | D | 14.22 | 7,500 | 106,650 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | D | 17.14 | 813 | 13,935 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | D | 69.40 | 4,403 | 305,568 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Sell | D | 99.25 | 853 | 84,660 | 0 | 853 to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Sell | D | 99.25 | 89,000 | 8,833,250 | 0 | 89 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 14.22 | 15,000 | 213,300 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 5.11 | 15,000 | 76,650 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 5.20 | 15,000 | 78,000 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 6.74 | 24,000 | 161,760 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 6.92 | 30,000 | 207,600 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Option Exercise | D | 14.22 | 18,000 | 255,960 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | D | 25.48 | 27,000 | 687,960 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 78.91 | 22,136 | 1,746,752 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 78.91 | 22,136 | 1,746,752 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 17.14 | 47,000 | 805,580 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 17.14 | 47,000 | 805,580 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 12.49 | 30,000 | 374,700 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 12.49 | 30,000 | 374,700 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 7.25 | 12,957 | 93,938 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 7.25 | 12,957 | 93,938 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 6.96 | 80,000 | 556,800 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 6.96 | 80,000 | 556,800 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 6.92 | 33,239 | 230,014 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 6.92 | 33,239 | 230,014 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 5.59 | 27,661 | 154,625 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 5.59 | 27,661 | 154,625 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 5.00 | 3,849 | 19,245 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 5.00 | 3,849 | 19,245 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 0.00 | 4,375 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 0.00 | 4,375 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | D | 99.25 | 44,194 | 4,386,255 | 0 | 44.2 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | D | 99.25 | 44,194 | 4,386,255 | 0 | 44.2 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 78.91 | 25,299 | 1,996,344 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 78.91 | 25,299 | 1,996,344 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 69.34 | 28,793 | 1,996,507 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 69.34 | 28,793 | 1,996,507 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 4,004 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 4,004 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 8,008 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 8,008 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | D | 99.25 | 10,488 | 1,040,934 | 0 | 10.5 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | D | 99.25 | 10,488 | 1,040,934 | 0 | 10.5 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 78.91 | 73,788 | 5,822,611 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 78.91 | 73,788 | 5,822,611 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 37.81 | 84,100 | 3,179,821 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 37.81 | 84,100 | 3,179,821 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 21.21 | 394,000 | 8,356,740 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 21.21 | 394,000 | 8,356,740 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 14,584 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 14,584 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 12,890 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 12,890 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | D | 99.25 | 231,311 | 22,957,617 | 0 | 231.3 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | D | 99.25 | 231,311 | 22,957,617 | 0 | 231.3 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 78.91 | 31,623 | 2,495,371 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 78.91 | 31,623 | 2,495,371 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 15.30 | 30,000 | 459,000 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 15.30 | 30,000 | 459,000 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,250 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,250 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Sell | D | 99.25 | 30,132 | 2,990,601 | 0 | 30.1 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Sell | D | 99.25 | 30,132 | 2,990,601 | 0 | 30.1 K to 0 (-100.00 %) |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 78.91 | 25,299 | 1,996,344 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 37.81 | 28,400 | 1,073,804 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 19.96 | 61,000 | 1,217,560 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 0.00 | 6,930 | 0 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | D | 99.25 | 68,985 | 6,846,761 | 0 | 69 K to 0 (-100.00 %) |
Jun 03 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | S | 99.28 | 751 | 74,559 | 10,255 | 11 K to 10.3 K (-6.82 %) |
May 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Option Exercise | M | 14.22 | 9,000 | 127,980 | 18,000 | |
May 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Sell | S | 99.70 | 9,000 | 897,300 | 794 | 9.8 K to 794 (-91.89 %) |
May 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Buy | M | 14.22 | 9,000 | 127,980 | 9,794 | 794 to 9.8 K (+1,133.50 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 98.93 | 72,385 | 7,161,048 | 0 | 72.4 K to 0 (-100.00 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 99.41 | 199,865 | 19,868,580 | 72,385 | 272.3 K to 72.4 K (-73.41 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 100.60 | 81,631 | 8,212,079 | 272,250 | 353.9 K to 272.3 K (-23.07 %) |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | M | 14.22 | 24,000 | 341,280 | 0 | |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | M | 5.11 | 15,000 | 76,650 | 0 | |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | M | 5.20 | 12,500 | 65,000 | 0 | |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | M | 6.74 | 7,500 | 50,550 | 0 | |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | M | 6.92 | 30,000 | 207,600 | 0 | |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Buy | M | 14.22 | 24,000 | 341,280 | 89,000 | 65 K to 89 K (+36.92 %) |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Buy | M | 5.11 | 15,000 | 76,650 | 65,000 | 50 K to 65 K (+30.00 %) |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Buy | M | 5.20 | 12,500 | 65,000 | 50,000 | 37.5 K to 50 K (+33.33 %) |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Buy | M | 6.74 | 7,500 | 50,550 | 37,500 | 30 K to 37.5 K (+25.00 %) |
Apr 04 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Buy | M | 6.92 | 30,000 | 207,600 | 30,000 | 0 to 30 K |
Apr 29 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Sell | S | 66.33 | 3,125 | 207,281 | 30,132 | 33.3 K to 30.1 K (-9.40 %) |
Mar 22 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 60.46 | 27,800 | 1,680,680 | 230,311 | 258.1 K to 230.3 K (-10.77 %) |
Mar 22 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 59.89 | 9,700 | 580,936 | 258,111 | 267.8 K to 258.1 K (-3.62 %) |
Mar 04 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 64.88 | 1,829 | 118,672 | 67,985 | 69.8 K to 68 K (-2.62 %) |
Mar 04 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 64.22 | 3,696 | 237,348 | 69,814 | 73.5 K to 69.8 K (-5.03 %) |
Mar 04 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 63.56 | 1,875 | 119,166 | 73,510 | 75.4 K to 73.5 K (-2.49 %) |
Mar 04 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 62.23 | 1,600 | 99,566 | 75,385 | 77 K to 75.4 K (-2.08 %) |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | A | 0.00 | 4,375 | 0 | 4,375 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | A | 78.91 | 22,136 | 1,746,752 | 22,136 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Grant | A | 0.00 | 4,375 | 0 | 44,044 | 39.7 K to 44 K (+11.03 %) |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | A | 78.91 | 25,299 | 1,996,344 | 25,299 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Grant | A | 0.00 | 5,000 | 0 | 76,985 | 72 K to 77 K (+6.95 %) |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | A | 0.00 | 6,250 | 0 | 6,250 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | A | 78.91 | 31,623 | 2,495,371 | 31,623 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Grant | A | 0.00 | 6,250 | 0 | 33,257 | 27 K to 33.3 K (+23.14 %) |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | A | 0.00 | 14,584 | 0 | 14,584 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | A | 78.91 | 73,788 | 5,822,611 | 73,788 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Grant | A | 0.00 | 14,584 | 0 | 267,811 | 253.2 K to 267.8 K (+5.76 %) |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 78.91 | 25,299 | 1,996,344 | 25,299 | |
Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Grant | A | 0.00 | 5,000 | 0 | 11,006 | 6 K to 11 K (+83.25 %) |
Apr 15 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | C | 31.05 | 257,647 | 7,999,939 | 353,881 | 96.2 K to 353.9 K (+267.73 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 71.40 | 400 | 28,560 | 96,234 | 96.6 K to 96.2 K (-0.41 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 70.05 | 3,868 | 270,953 | 96,634 | 100.5 K to 96.6 K (-3.85 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 75.57 | 6,820 | 515,387 | 100,502 | 107.3 K to 100.5 K (-6.35 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 74.13 | 200 | 14,826 | 107,322 | 107.5 K to 107.3 K (-0.19 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 73.29 | 2,272 | 166,515 | 107,522 | 109.8 K to 107.5 K (-2.07 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 72.15 | 13,000 | 937,950 | 109,794 | 122.8 K to 109.8 K (-10.59 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 71.44 | 99,981 | 7,142,643 | 122,794 | 222.8 K to 122.8 K (-44.88 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 70.33 | 102,760 | 7,227,111 | 222,775 | 325.5 K to 222.8 K (-31.57 %) |
Jan 25 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 7.55 | 11,800 | 89,090 | 0 | |
Jan 25 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 7.55 | 11,800 | 89,090 | 39,081 | 27.3 K to 39.1 K (+43.25 %) |
Jan 21 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | M | 19.96 | 20,000 | 399,200 | 61,000 | |
Jan 21 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 96.95 | 200 | 19,390 | 70,985 | 71.2 K to 71 K (-0.28 %) |
Jan 21 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 96.00 | 5,300 | 508,797 | 71,185 | 76.5 K to 71.2 K (-6.93 %) |
Jan 21 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 95.29 | 13,300 | 1,267,313 | 76,485 | 89.8 K to 76.5 K (-14.81 %) |
Jan 21 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 93.92 | 1,200 | 112,704 | 89,785 | 91 K to 89.8 K (-1.32 %) |
Jan 21 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Buy | M | 19.96 | 20,000 | 399,200 | 90,985 | 71 K to 91 K (+28.17 %) |
Jan 19 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 89.57 | 1,466 | 131,310 | 27,281 | 28.7 K to 27.3 K (-5.10 %) |